Evotec

History

Year	Detail
1993	Evotec was initially founded as Evotec BioSystems GmbH in Hamburg, Germany.
1996	Evotec collaborated with Novartis and SmithKlineBeecham to develop EVOscreen.
1999	The company established Evotec Neurosciences GmbH in Hamburg.
2000	Evotec merged with Oxford Asymmetry International plc and formed Evotec OAI AG.
2006	Evotec sold Evotec Technologies to PerkinElmer.
2010	Evotec collaborated with MedImmune in the diabetes therapeutic area.
2012	Evotec partnered its EVT100 series with Janssen Pharmaceuticals.
2013	Evotec acquired Cell Culture Service GmbH.
2017	Evotec acquired Aptuit.
2019	Evotec and Galapagos collaborated in the field of fibrosis.
2020	Evotec and Novo Nordisk partnered to develop novel therapies for kidney diseases.
2021	Evotec and Chinook Therapeutics collaborated to discover and develop novel precision medicines for chronic kidney diseases.
2022	Evotec and BMS extended and expanded their strategic partnership in protein degradation.
2023	Evotec and Bristol Myers Squibb extended a strategic neurodegeneration partnership.